Acteoside Suppresses RANKL-Mediated Osteoclastogenesis by Inhibiting c-Fos Induction and NF-κB Pathway and Attenuating ROS Production

Documenti analoghi

• Eudebeiolide B Inhibits Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Regulating RANKL-Induced NF-κB, c-Fos and Calcium Signaling
  di: Kim, Mi-Hwa, et al.
  Pubblicazione: (2020)
• Agelasine D Suppresses RANKL-Induced Osteoclastogenesis via Down-Regulation of c-Fos, NFATc1 and NF-κB
  di: Kang, Moo Rim, et al.
  Pubblicazione: (2014)
• C-phycocyanin attenuates RANKL-induced osteoclastogenesis and bone resorption in vitro through inhibiting ROS levels, NFATc1 and NF-κB activation
  di: AlQranei, Mohammed S., et al.
  Pubblicazione: (2020)
• The Association of Notch2 and NF-κB Accelerates RANKL-Induced Osteoclastogenesis
  di: Fukushima, Hidefumi, et al.
  Pubblicazione: (2008)
• Maackiain dampens osteoclastogenesis via attenuating RANKL‐stimulated NF‐κB signalling pathway and NFATc1 activity
  di: Liu, Yuhao, et al.
  Pubblicazione: (2020)